Monocyte HLA-DR Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia

Mediterr J Hematol Infect Dis. 2022 Nov 1;14(1):e2022078. doi: 10.4084/MJHID.2022.078. eCollection 2022.

Romain Fort^{1

2

3}, Guillaume Monneret⁴, Elie Nader^{2

3}, Giovanna Cannas¹, Philippe Connes^{2

3}, Fabienne Venet⁴, Arnaud Hot¹

¹ Department of Internal Medicine, Edouard Herriot University Hospital, Lyon, France.
² LIBM EA7424 Laboratory, Equipe "Biologie Vasculaire et du Globule Rouge", Claude Bernard University, Lyon, France.
³ Excellence du Globule Rouge (LABEX GR-Ex) Laboratory, PRES Sorbonne, Paris, France.
⁴ Cellular Immunology Laboratory, Edouard Herriot University Hospital, Lyon, France.

No abstract available

Keywords: HLA-DR expression; Immune response; Infection; Prognosis; Sickle cell anemia; Vaso-occlusive crisis.